Tag Archives: churning

Merck’s cancer meds keep churning amid COVID-19, but vaccines stumble

Earlier this year, Merck warned investors that the COVID-19 pandemic would take a multbillion-dollar bite out of its revenue expectations for 2020. And in the second quarter, that prediction took shape. The pandemic hurt Merck’s pharmaceutical sales by about $ 1.5 billion from April to June, the drugmaker reported, despite continued growth for its cancer medicines. Sales… Read More »